Abstract
Lamotrigine [‘Lamictal’], one of the new generation of anticonvulsants, has been effectively used in adults with a variety of epilepsies and seizures as adjunctive therapy in refractory disease, and, more recently, as monotherapy in less severe seizures. Recently, lamotrigine has been advocated for use in children with difficult-to-treat seizures. Numerous studies exploring the efficacy of lamotrigine therapy were presented at the 23rd International Epilepsy Congress [ Prague, Czech Republic; September 1999 ].
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Hunt, L. Lamotrigine. Inpharma Wkly. 1212, 11–12 (1999). https://doi.org/10.2165/00128413-199912120-00025
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199912120-00025